In contrast, lung cancer samples express high levels of PRMT5, WDR77, ErbB2, ErbB3 and FGFR3 and decreased levels of GLIPR1, Leprel1 and BTG2 (Additional file 8: Figure S7). The gene discussed is ERBB2; the disease is lung carcinoma.